Myriad Genetics | MYGN - Los Gastos Financieros De La Deuda





Los Gastos Financieros De La Deuda Cambio Fecha
Agilent USD 29M 4M 2026-06
Becton, Dickinson and Co. USD 132M 17M 2026-06
Bio-Rad Laboratories USD 12.1M 200K 2026-06
Bruker USD 17.8M 9.7M 2026-06
Danaher USD 135M 28M 2026-09
Illumina USD 24M 0 2026-06
J&J USD 43M 25M 2026-03
Mettler Toledo International USD 17.25M 239K 2026-06
Myriad Genetics USD 4.4M 600K 2025-12
OraSure Technologies 1.67M 1.13M 2025-12
Pacific Biosciences Of California USD 1.74M 1000 2025-12
Quest Diagnostics USD 61M 8M 2026-09
Quidel USD 5.63B 5.58B 2026-03
Repligen USD 5.71M 49K 2026-09
Revvity USD 22.99M 1.73M 2026-06
Standard Biotools USD 5K 5K 2025-12
Thermo Fisher Scientific USD 417M 63M 2026-09
Veracyte USD 2K 1000 2023-12
Waters USD 55M 13M 2026-06